Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,160
-240 (-1.67%)
At close: Apr 2, 2026

Cell Biotech Revenue

In the year 2025, Cell Biotech had annual revenue of 53.13B KRW with 6.44% growth. Cell Biotech had revenue of 14.63B in the quarter ending December 31, 2025, with 20.38% growth.

Revenue
53.13B
Revenue Growth
+6.44%
P/S Ratio
1.82
Revenue / Employee
526.00M
Employees
101
Market Cap
96.91B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202553.13B3.21B6.44%
Dec 31, 202449.91B-3.87B-7.20%
Dec 31, 202353.79B3.26B6.46%
Dec 31, 202250.53B3.65B7.79%
Dec 31, 202146.87B1.29B2.83%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CTCBIO123.77B
KoBioLabs69.29B
Choong Ang Vaccine Laboratory39.19B
CORESTEMCHEMON20.16B
BIO-FD&C19.18B
TegoScience5.94B
Quratis2.46B
NovMetaPharma1.30B
Revenue Rankings